Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Current Leases: 2019-2025

Historic Current Leases for BIO-TECHNE (TECH) over the last 6 years, with Sep 2025 value amounting to $13.8 million.

  • BIO-TECHNE's Current Leases rose 2.12% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 2.12%. This contributed to the annual value of $14.1 million for FY2025, which is 9.12% up from last year.
  • According to the latest figures from Q3 2025, BIO-TECHNE's Current Leases is $13.8 million, which was down 2.32% from $14.1 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Current Leases ranged from a high of $14.1 million in Q2 2025 and a low of $10.4 million during Q1 2021.
  • Its 3-year average for Current Leases is $12.9 million, with a median of $13.0 million in 2024.
  • In the last 5 years, BIO-TECHNE's Current Leases rose by 23.79% in 2021 and then dropped by 9.62% in 2023.
  • BIO-TECHNE's Current Leases (Quarterly) stood at $11.8 million in 2021, then declined by 7.06% to $11.0 million in 2022, then climbed by 15.46% to $12.7 million in 2023, then increased by 6.62% to $13.5 million in 2024, then increased by 2.12% to $13.8 million in 2025.
  • Its last three reported values are $13.8 million in Q3 2025, $14.1 million for Q2 2025, and $14.0 million during Q1 2025.